Advanced Cell Diagnostics, Inc v Molecular Instruments, Inc

Advanced Cell Diagnostics, Inc v Molecular Instruments, Inc

The patents are invalid for obviousness over Collins in combination with Kern. The skilled person, motivated by the prior art, would have found it obvious to use bDNA with cruciform probes in situ, with a reasonable expectation of success. There was no technical prejudice or mindset deterring the skilled person from making this combination. The patents are not anticipated by Collins or Collins with Kern, as the disclosures do not meet the standard for anticipation. Had the patents been valid, MI's acts of bespoke troubleshooting with customers would have made it jointly liable for infringement of EP572, but not EP439, under the proper construction of the claims.

Parties
Claimant: Advanced Cell Diagnostics, Inc.; Defendant: Molecular Instruments, Inc.
Jurisdiction
England and Wales
Judgment Date
25 November 2024
Procedural Posture
Patent Infringement and Revocation / First Instance Judgment
Outcome
Patents held invalid for obviousness; no relief granted. Had the patents been valid, EP572 would have been infringed by MI's acts of joint liability with customers, but not EP439.
Legal Topics
Patent Infringement, Patent Validity, Obviousness, Anticipation, Joint Tortfeasorship, Claim Construction, Sufficiency, Added Matter

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 5 Authorities cited 9 Party arguments 2
Sign in to unlock

Parties

Advanced Cell Diagnostics, Inc.

Claimant

Molecular Instruments, Inc.

Defendant

Procedural Posture

Patent Infringement and Revocation / First Instance Judgment

  1. 1 Whether the defendant infringed European Patents (UK) No. 1 910 572 B1 and No. 2 500 439 B1
  2. 2 Whether the patents are invalid for obviousness or anticipation
  3. 3 Whether the defendant is jointly liable with its customers for acts of infringement

Ratio Decidendi

The patents are invalid for obviousness over Collins in combination with Kern. The skilled person, motivated by the prior art, would have found it obvious to use bDNA with cruciform probes in situ, with a reasonable expectation of success. There was no technical prejudice or mindset deterring the skilled person from making this combination. The patents are not anticipated by Collins or Collins with Kern, as the disclosures do not meet the standard for anticipation. Had the patents been valid, MI's acts of bespoke troubleshooting with customers would have made it jointly liable for infringement of EP572, but not EP439, under the proper construction of the claims.

Court Disposition

Patents held invalid for obviousness; no relief granted. Had the patents been valid, EP572 would have been infringed by MI's acts of joint liability with customers, but not EP439.